No abstract available
MeSH terms
-
AIDS Vaccines / therapeutic use
-
Administration, Intranasal
-
Administration, Intravaginal
-
Animals
-
Anti-Infective Agents, Local / therapeutic use
-
Antibodies / administration & dosage
-
Antibodies / therapeutic use*
-
Antiviral Agents / administration & dosage
-
Antiviral Agents / chemistry
-
Antiviral Agents / therapeutic use*
-
Cellulose / analogs & derivatives
-
Cellulose / therapeutic use
-
Chemistry Techniques, Analytical
-
Copper / therapeutic use
-
Drug Design
-
HIV Infections / drug therapy
-
HIV Infections / virology
-
HIV-1 / drug effects
-
HIV-1 / immunology
-
Herpes Simplex / drug therapy
-
Herpes Simplex / virology
-
Herpesvirus 2, Human / drug effects
-
Humans
-
Influenza A Virus, H5N2 Subtype / immunology
-
Japanese Encephalitis Vaccines / therapeutic use
-
Oligosaccharides / therapeutic use
-
Poxviridae / immunology
-
Severity of Illness Index
-
Vaccines, Attenuated / therapeutic use
-
Vaccines, DNA / therapeutic use
-
Viral Vaccines / administration & dosage
-
Viral Vaccines / chemistry
-
Viral Vaccines / therapeutic use*
-
Virus Diseases / drug therapy*
-
Virus Diseases / transmission
-
Virus Diseases / virology
Substances
-
AIDS Vaccines
-
Anti-Infective Agents, Local
-
Antibodies
-
Antiviral Agents
-
Japanese Encephalitis Vaccines
-
Oligosaccharides
-
Vaccines, Attenuated
-
Vaccines, DNA
-
Viral Vaccines
-
cellulose acetate 1,2-benzenedicarboxylate
-
Copper
-
Cellulose
-
cupric oxide